BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1572277)

  • 1. Production of immunoreactive forms of growth hormone by the Burkitt tumor serum-free cell line sfRamos.
    Baglia LA; Cruz D; Shaw JE
    Endocrinology; 1992 May; 130(5):2446-54. PubMed ID: 1572277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Epstein-Barr virus-negative Burkitt lymphoma cell line (sfRamos) secretes a prolactin-like protein during continuous growth in serum-free medium.
    Baglia LA; Cruz D; Shaw JE
    Endocrinology; 1991 May; 128(5):2266-72. PubMed ID: 1850347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone expression in human Burkitt lymphoma serum-free Ramos cell line.
    Lytras A; Quan N; Vrontakis ME; Shaw JE; Cattini PA; Friesen HG
    Endocrinology; 1993 Feb; 132(2):620-8. PubMed ID: 7678796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum.
    Tanaka T; Shiu RP; Gout PW; Beer CT; Noble RL; Friesen HG
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1058-63. PubMed ID: 7419681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells.
    Nickel BE; Kardami E; Cattini PA
    Endocrinology; 1990 Feb; 126(2):971-6. PubMed ID: 2298178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of human growth hormone and prolactin secreted in vitro: Immunoassay and radioreceptor assay correlations.
    Guyda JH
    J Clin Endocrinol Metab; 1975 Nov; 41(5):953-67. PubMed ID: 1184726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone synthesis and secretion by a somatomammotroph cell line derived from normal adult pituitary of the rat.
    Chomczynski P; Brar A; Frohman LA
    Endocrinology; 1988 Nov; 123(5):2276-83. PubMed ID: 2844507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of growth hormone binding protein from IM-9 lymphocytes by endopeptidase is dependent on sulfhydryl group inactivation.
    Trivedi B; Daughaday WH
    Endocrinology; 1988 Nov; 123(5):2201-6. PubMed ID: 2844506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic cleavage of human growth hormone (hGH) by rat tissues in vitro: influence on the kinetics of exogenously administered hGH.
    Wroblewski VJ; Masnyk M; Becker GW
    Endocrinology; 1991 Jul; 129(1):465-74. PubMed ID: 2055201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular nature of circulating growth hormone in normal and acromegalic man: evidence for a principal and minor monomeric forms.
    Baumann G; MacCart JG; Amburn K
    J Clin Endocrinol Metab; 1983 May; 56(5):946-52. PubMed ID: 6339541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone-dependent events in the adipose differentiation of 3T3-F442A fibroblasts: modulation of macromolecular synthesis.
    Guller S; Sonenberg M; Wu KY; Szabo P; Corin RE
    Endocrinology; 1989 Nov; 125(5):2360-7. PubMed ID: 2477229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone.
    Shiu RP; Paterson JA
    Cancer Res; 1984 Mar; 44(3):1178-86. PubMed ID: 6692402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and release of calcitonin-like immunoreactivity by anterior pituitary cells: evidence for a role in paracrine regulation of prolactin secretion.
    Shah GV; Deftos LJ; Crowley WR
    Endocrinology; 1993 Mar; 132(3):1367-72. PubMed ID: 8440192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human growth hormone (GH)-releasing factor stimulates and somatostatin inhibits the release of rat GH variants.
    Yokoya S; Friesen HG
    Endocrinology; 1986 Nov; 119(5):2097-105. PubMed ID: 2876884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone in the male reproductive tract of the chicken: heterogeneity and changes during ontogeny and maturation.
    Luna M; Huerta L; Berumen L; Martínez-Coria H; Harvey S; Arámburo C
    Gen Comp Endocrinol; 2004 May; 137(1):37-49. PubMed ID: 15094334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of prolactin secreted by human prolactinoma cells: immunological, receptor binding, and biological properties of the glycosylated and nonglycosylated forms.
    Pellegrini I; Gunz G; Ronin C; Fenouillet E; Peyrat JP; Delori P; Jaquet P
    Endocrinology; 1988 Jun; 122(6):2667-74. PubMed ID: 3131120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of IM-9 cells with human growth hormone (GH) promotes rapid disulfide linkage of the GH receptor.
    Frank SJ; Gilliland G; Van Epps C
    Endocrinology; 1994 Jul; 135(1):148-56. PubMed ID: 8013347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H; Refetoff S; Fang VS
    Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of human growth hormone polypeptides: purified from pituitary extracts and synthesized in monkey kidney cells and bacteria.
    Hizuka N; Hendricks CM; Pavlakis GN; Hamer DH; Gorden P
    J Clin Endocrinol Metab; 1982 Sep; 55(3):545-50. PubMed ID: 6284784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of lactogenic activities of ovine prolactin and human growth hormone (hGH) by a novel form of a modified recombinant hGH.
    Gertler A; Shamay A; Cohen N; Ashkenazi A; Friesen HG; Levanon A; Gorecki M; Aviv H; Hadary D; Vogel T
    Endocrinology; 1986 Feb; 118(2):720-6. PubMed ID: 2417826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.